However, in the HT-29 cell line, CARD11 seemed to be more involved with the activation of chemotaxis and extra-cellular matrix (ECM) pathways, which are seen in metastatic cancers, suggesting that perhaps HT-29 is possibly more invasive. Here, CARD11 is linked to metastatic malignant neoplasm.